9 completed. 9 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 9 |
| Phase 2 | 1 | Completed 1 |
Follow Acute Myelogenous Leukemia: new trials by email Literature Review of Acute Myelogenous Leukemia trials Research Report on Acute Myelogenous Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies Radiation, Cyclophosphamide, Donor Lymphocyte Infusion (DLI) - Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia | Phase 3 | Completed | Northwell Health | 10 | 2014-12-01 | 2022-04-07 |
| P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies Infusion of one MPC expanded cord unit and one unexpanded cord unit, Infusion of two unexpanded cord blood units. - Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia | Phase 3 | Completed | Mesoblast, Ltd. | 49 | 2013-08-01 | 2020-06-26 |
| Double Cord Versus Haploidentical (BMT CTN 1101) Haploidentical Bone Marrow Transplant, Double Umbilical Cord Blood Transplant - Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia | Phase 3 | Completed | Medical College of Wisconsin | 368 | 2012-06-01 | 2021-12-01 |
| A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS Procrit - Acute Myelogenous Leukemia, Myelodysplastic Syndrome | Phase 3 | Completed | M.D. Anderson Cancer Center | 51 | 2008-03-01 | 2018-05-30 |
| Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) Single Umbilical Cord Blood Unit Transplant, Double Umbilical Cord Blood Unit Transplant, Total Body Irradiation - Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia | Phase 3 | Completed | Medical College of Wisconsin | 224 | 2006-12-01 | 2021-10-28 |
| A Remission Induction Therapy and Risk-oriented Postremission Strategy for Adult Acute Myelogenous Leukemia (AML) cytosine arabinoside - Acute Myelogenous Leukemia | Phase 3 | Completed | Northern Italy Leukemia Group | 573 | 2006-11-01 | 2016-03-31 |
| A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I) clofarabine (IV formulation), placebo, cytarabine - Acute Myelogenous Leukemia | Phase 3 | Completed | Genzyme, a Sanofi Company | 326 | 2006-08-01 | 2014-04-14 |
| Randomized Study of Decitabine in Maintenance Therapy of Acute Myeloid Leukemia (AML) Decitabine - Acute Myelogenous Leukemia | Phase 2 / Phase 3 | Completed | M.D. Anderson Cancer Center | 50 | 2006-08-01 | 2013-03-04 |
| High Dose Daunorubicin Vs. Standard Dose Daunorubicin in Induction Treatment of AML arm II - ACUTE MYELOGENOUS LEUKEMIA | Phase 3 | Completed | Cooperative Study Group A for Hematology | 398 | 2001-08-01 | 2011-06-10 |
Leukemia, Myeloid, Acute (9) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (4) · Hodgkin Disease (3) · Leukemia (3) · Lymphoma (3) · Lymphoma, Non-Hodgkin (3) · Myelodysplastic Syndromes (3) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Burkitt Lymphoma (1) · Lymphoma, Follicular (1) · Lymphoma, Mantle-Cell (1)
Hematologic Diseases (9) · Hemic and Lymphatic Diseases (9) · Leukemia, Myeloid (9) · Neoplasms (9) · Neoplasms by Histologic Type (9) · Leukemia (6) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Leukemia, Lymphoid (4) · Lymphatic Diseases (4) · Lymphoproliferative Disorders (4) · Bone Marrow Diseases (3) · Chronic Disease (2) · Disease Attributes (2) · Myeloproliferative Disorders (2)
Cyclophosphamide (2) · Cytarabine (2) · Whole-Body Irradiation (2) · Clofarabine (1) · Cyclosporine (1) · Daunorubicin (1) · Decitabine (1) · Dosage Forms (1) · Epoetin Alfa (1) · Mycophenolic Acid (1) · Radiation (1) · fludarabine (1) · fludarabine phosphate (1)
M.D. Anderson Cancer Center (2) · Medical College of Wisconsin (2) · Cooperative Study Group A for Hematology (1) · Genzyme, a Sanofi Company (1) · Mesoblast, Ltd. (1) · Northern Italy Leukemia Group (1) · Northwell Health (1)
United States (7) · Canada (2) · Italy (2) · Australia (1) · France (1) · Germany (1) · South Korea (1)
Mary Horowitz, MD, MS (2) · Donna Skerrett, MD, MS (1) · Elizabeth J. Shpall, MD (1) · Farhad Ravandi-Kashani, MD (1) · Je Hwan Lee, professor (1) · Joel A Brochstein, MD (1) · Jorge E. Cortes, M.D. (1) · Renato Bassan, MD (1)
PMID 21828126, PMID 22585697, PMID 25354103, PMID 30948365, PMID 31978214, PMID 32855275, PMID 33475736, PMID 34273598, PMID 37088401, PMID 37120135, PMID 39846144, PMID 41350757
U24CA076518 (2), 2008 (1), U01HL069294 (1), U10HL069294 (1)